Johnson & Johnson
NYSE: JNJNew Brunswick, US · Incorporated in New Jersey · 7 known investors
Johnson & Johnson is a diversified healthcare company operating across 260 subsidiary companies with approximately 138,000 employees globally. The organization develops pharmaceuticals, medical devices, and healthcare solutions across therapeutic areas including cardiology, oncology, immunology, neuroscience, and orthopaedics, alongside digital health and surgical robotics technologies.
Investors · 7
Acquisitions · 5
Early investors' stakes continue via these dealsDeveloper of drug-eluting stents for coronary artery disease; IPO'd in 2004 and acquired by J&J in 2007.
Developed next-generation protein drugs for inflammatory diseases and cancer; acquired by J&J in 2014.
Developed a bio-erodable femoral closure device; acquired by Johnson & Johnson for up to $90M.
Developer of the EmboTrap stroke treatment device for removing clots from the brain; acquired by Johnson & Johnson.
Originator of Inlexzo (gemcitabine intravesical system), an FDA-approved treatment for certain bladder cancers; acquired by Johnson & Johnson in 2019.